SynAct Pharma AB Statistics

Total Valuation

SynAct Pharma AB has a market cap or net worth of SEK 519.53 million. The enterprise value is 482.46 million.

Market Cap	519.53M
Enterprise Value	482.46M

Important Dates

The next estimated earnings date is Tuesday, February 18, 2025.

Earnings Date	Feb 18, 2025
Ex-Dividend Date	n/a

Share Statistics

SynAct Pharma AB has 48.78 million shares outstanding. The number of shares has increased by 22.54% in one year.

Current Share Class	n/a
Shares Outstanding	48.78M
Shares Change (YoY)	+22.54%
Shares Change (QoQ)	+4.79%
Owned by Insiders (%)	13.17%
Owned by Institutions (%)	14.08%
Float	27.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	2.60
P/TBV Ratio	30.30
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.12
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.88, with a Debt / Equity ratio of 0.01.

Current Ratio	3.88
Quick Ratio	3.42
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-41.01

Financial Efficiency

Return on equity (ROE) is -81.55% and return on invested capital (ROIC) is -24.48%.

Return on Equity (ROE)	-81.55%
Return on Assets (ROA)	-18.93%
Return on Capital (ROIC)	-24.48%
Revenue Per Employee	n/a
Profits Per Employee	-30.91M
Employee Count	5
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +46.10% in the last 52 weeks. The beta is 0.73, so SynAct Pharma AB's price volatility has been lower than the market average.

Beta (5Y)	0.73
52-Week Price Change	+46.10%
50-Day Moving Average	9.79
200-Day Moving Average	8.51
Relative Strength Index (RSI)	57.05
Average Volume (20 Days)	162,599

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-74.69M
Pretax Income	-161.05M
Net Income	-154.57M
EBITDA	n/a
EBIT	-74.69M
Earnings Per Share (EPS)	-4.08

Full Income Statement

Balance Sheet

The company has 38.49 million in cash and 1.43 million in debt, giving a net cash position of 37.06 million or 0.76 per share.

Cash & Cash Equivalents	38.49M
Total Debt	1.43M
Net Cash	37.06M
Net Cash Per Share	0.76
Equity (Book Value)	169.16M
Book Value Per Share	4.10
Working Capital	47.18M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-91.81M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SynAct Pharma AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.54%
Shareholder Yield	-22.54%
Earnings Yield	-38.32%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a